4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000121
CHIEF EXECUTIVE OFFICER sold 2,366 shares at an average $92.25 ($218,253)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-12-09 | Sale 10b5-1 | −961 | $92.06 | $88,470 | 136,437 | I |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-12-09 | Sale 10b5-1 | −222 | $93.10 | $20,668 | 136,215 | I |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-12-09 | Sale 10b5-1 | −1,029 | $92.03 | $94,701 | 136,369 | I |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-12-09 | Sale 10b5-1 | −154 | $93.60 | $14,414 | 136,215 | I |
| Open-market sales · 2,366 sh · avg $92.25 · $218,253 | |||||||
Loading xslF345X05/wk-form4_1733865045.xml…